Bristol-Myers Squibb Company Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (75)

Latest Posts

About This Stock More About This Stock
Johns Hopkins, Bristol-Myers Face $1 Billion Suit
Article By: Tyler Durden
Sunday, January 20, 2019 1:05 PM EST
Johns Hopkins University, Bristol-Myers Squibb and the Rockefeller Foundation must face a $1 billion lawsuit over their roles in a top-secret program in the 1940s ran by the US government that injected hundreds of Guatemalans with syphilis.
In this article: BMY
Read
Bristol-Myers To Acquire Celgene, Puts Healthcare ETFs In Focus
Article By: Sweta Killa
Thursday, January 3, 2019 11:00 PM EST
The healthcare space is witnessing a wave of mergers and acquisitions, which could change the landscape of the healthcare business.
In this article: BMY, IBB, CELG, BBH, IHE, PJP, IEIH Also: BLUE
Read
E Bristol-Myers To Buy Celgene; A $74 Billion Deal
Article By: TalkMarkets DailyTalk
Thursday, January 3, 2019 7:31 AM EST
Bristol-Myers Squibb has struck a deal to buy Celgene in a deal valued at $74 billion in equity and cash.
In this article: BMY, CELG
Read
5 Beaten Down Stocks Of Spooky October With Upside Potential
Article By: Sweta Killa
Thursday, November 1, 2018 12:30 PM EST
Here are five stocks from the S&P 500 Index that were hit badly by market turmoil but might reverse the trend. These stocks saw positive earnings estimate revisions last month.
In this article: AMZN, NFX, BMY, ETN, CF Also: MSFT, NVDA, FB, AAPL
Read
Bristol-Myers Squibb Is Prepared To Heal Itself
Article By: Fredrik Arnold
Friday, October 19, 2018 5:50 AM EST
BMY's price per share was $56.02 at yesterday's market close. A year ago its price was $63.70 for a price loss of $7.68 per share for the year.
In this article: BMY
Read

PARTNER HEADLINES

Latest Tweets for $BMY

No tweets yet!

$BMY

OncoSec Raising Its Profile In Fight Against Cancer
Dick Kaplan 9/6/2017 4:03:09 PM

Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY

1 to 1 of 1 comments